Transgenic mouse expressing a full-length hepatitis C virus cDNA

Jpn J Cancer Res. 1998 Feb;89(2):150-8. doi: 10.1111/j.1349-7006.1998.tb00543.x.

Abstract

Hepatitis C virus (HCV), a major causative agent of post transfusion non-A, non-B hepatitis (NANBH), can only infect humans and chimpanzees. We produced nine transgenic mouse lines carrying a full-length HCV cDNA with the human serum amyloid P component (hSAP) promoter that can direct liver-specific expression. In one of these lines HCV mRNA and HCV core protein were detected in the liver of the transgenic mouse, although the levels of expression were very low. In addition, HCV-related antibody was detected in the serum.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Alanine Transaminase / blood
  • Animals
  • Aspartate Aminotransferases / blood
  • DNA, Viral / genetics*
  • DNA, Viral / metabolism
  • Hepacivirus / genetics*
  • Hepatitis C Antibodies / biosynthesis
  • Hepatitis C Antibodies / blood
  • Humans
  • Immunohistochemistry
  • Liver / metabolism
  • Liver / pathology
  • Mice
  • Mice, Inbred BALB C
  • Mice, Transgenic
  • Polymerase Chain Reaction
  • Promoter Regions, Genetic
  • RNA, Viral / genetics
  • RNA, Viral / metabolism
  • Sensitivity and Specificity
  • Serum Amyloid P-Component / metabolism
  • Transcription, Genetic

Substances

  • DNA, Viral
  • Hepatitis C Antibodies
  • RNA, Viral
  • Serum Amyloid P-Component
  • Aspartate Aminotransferases
  • Alanine Transaminase